SCHEMBL7164261

SCHEMBL7164261

CCOC(=O)c1c[nH]c2cc(F)c(C)cc2c1=O

nearest known ligand 0.63

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.63
GABRB2 P47870 3/20 0.63
GABRB1 P18505 2/20 0.62
GABRA3 P34903 2/20 0.62
CYP1A2 P05177 1/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C19 P33261 1/20 0.57
MEN1 O00255 2/20 0.54
KMT2A Q03164 2/20 0.54
ALDH1A1 P00352 1/20 0.54
TP53 P04637 1/20 0.54
HPGD P15428 1/20 0.54
HSD17B10 Q99714 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
CLEC4M Q9H2X3 1/20 0.52
KDM4E B2RXH2 2/20 0.49
MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1242568 0.92 GABRA1 (0.70) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL28289153 0.89 GABRA1 (0.69) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL17242463 0.87 GABRA1 (0.66) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL18987742 0.87 GABRA1 (0.60) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL5514815 0.87 GABRA1 (0.63) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL2031515 0.86 GABRA1 (0.59) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL5681642 0.85 GABRA1 (0.60) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL10519075 0.85 GABRA1 (0.66) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL29576698 0.85 GABRA1 (0.60) GABRA1GABRB2GABRB1GABRA3CYP1A2
SCHEMBL12786969 0.84 GABRA1 (0.69) GABRA1GABRB2GABRB1GABRA3CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1355647-A2 THE TREATMENT OF SEXUAL DYSFUNCTION AND CARDIOVASCULAR DISEASE WITH QUINOLINONE ENANTIOMERS R.T. Alamo Ventures I, LLC (US) 2003-10-29 EP disclosed
WO-2002058703-A2 THE TREATMENT OF SEXUAL DYSFUNCTION AND CARDIOVASCULAR DISEASE WITH QUINOLINONE ENANTIOMERS R.T. ALAMO VENTURES I, LLC (US) 2002-08-01 WO disclosed